Nott 2019 PLAC

URL: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001373.v2.p2

Publications: Alexi Nott et al. ,Brain cell type–specific enhancer–promoter interactome maps and disease-risk association.Science366,1134-1139(2019).DOI:10.1126/science.aay0793

Funding/Acknowledgements: We thank J. Collier for technical assistance, L. Van Ael for manuscript preparation, D. Skola and M. L. Gage for manuscript editing, and M. Gymrek and S. Konermann for scientific discussions. Funding: Support was provided by NIH grant nos. NS096170, RF1 AG061060-01, R01 AG056511-01A1, and R01 AG057706-01; the Cure Alzheimer’s Fund Gifford Neuroinflammation Consortium; and UCSD Shiley-Marcos ADRC grant no. 1P30AG062429. A.N. was supported by the Alzheimer’s Association (grant no. AARF-18-531498) and the Altman Clinical & Translational Research Institute at UCSD (National Center for Advancing Translational Sciences, supported by NIH grant no. KL2TR001444). I.R.H. was supported by the VENI research program, which is financed by the Netherlands Organization for Scientific Research. N.G.C. was supported by NIH grant no. K08 NS109200-01 and The Hartwell Foundation. C.Z.H. was supported by the Cancer Research Institute Irvington Postdoctoral Fellowship Program. C.O. was funded by NIHNCI CCSG grant nos. P30 014195 and S10-OD023689. Salk facilities are supported by the Salk Cancer Center (NCI grant no. P30-CA014195). F.H.G. was supported by the JPB Foundation, the Engman Foundation, an AHA-Allen Initiative in Brain Health and Cognitive Impairment award made jointly through the American Heart Association and The Paul G. Allen Frontiers Group: 19PABH134610000, and the Dolby Foundation. J.B.B. and R.A.R. were supported by the UCSD Shiley-Marcos ADRC grant no. AG062429-01. Sequencing was conducted at the IGM Genomics Center, UCSD; the center was supported by grant nos. P30DK063491 and P30CA023100.